These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 15464713)

  • 1. Assessing the risk/benefit profile before recommending aspirin for the primary prevention of cardiovascular events.
    Rodondi N; Bauer DC
    Am J Med; 2004 Oct; 117(7):528-30. PubMed ID: 15464713
    [No Abstract]   [Full Text] [Related]  

  • 2. Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan.
    Morimoto T; Fukui T; Lee TH; Matsui K
    Am J Med; 2004 Oct; 117(7):459-68. PubMed ID: 15464702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin for the primary prevention of cardiovascular events: recommendations and rationale.
    U.S. Preventive Services Task Force
    Am J Nurs; 2002 Mar; 102(3):67, 69-70. PubMed ID: 11976531
    [No Abstract]   [Full Text] [Related]  

  • 4. Appropriate aspirin use for primary prevention of cardiovascular disease.
    Miser WF
    Am Fam Physician; 2011 Jun; 83(12):1380-6. PubMed ID: 21671538
    [No Abstract]   [Full Text] [Related]  

  • 5. Aspirin for the prevention of cardiovascular disease: recommendation statement.
    Am Fam Physician; 2011 Jun; 83(12):1464-8. PubMed ID: 21671547
    [No Abstract]   [Full Text] [Related]  

  • 6. Aspirin for primary prevention of cardiovascular disease events.
    Nemerovski CW; Salinitri FD; Morbitzer KA; Moser LR
    Pharmacotherapy; 2012 Nov; 32(11):1020-35. PubMed ID: 23019080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of aspirin in the primary prevention of cardiovascular disease].
    Rodondi N; Cornuz J
    Rev Med Suisse; 2006 Mar; 2(56):646-51. PubMed ID: 16597054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving outcomes with antiplatelet therapies in percutaneous coronary intervention and stenting.
    Hobson A; Curzen N
    Thromb Haemost; 2009 Jan; 101(1):23-30. PubMed ID: 19132185
    [No Abstract]   [Full Text] [Related]  

  • 9. [Aspirin in cardiovascular prevention: does the approach differ by gender?].
    Temizhan A
    Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():2-4. PubMed ID: 18160359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin for primary prevention: yes or no?
    Selak V; Elley CR; Wells S; Rodgers A; Sharpe N
    J Prim Health Care; 2010 Jun; 2(2):92-9. PubMed ID: 20690297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin for the primary prevention of cardiovascular events: recommendations and rationale.
    U.S. Preventive Services Task Force
    Am Fam Physician; 2002 May; 65(10):2107-10. PubMed ID: 12046780
    [No Abstract]   [Full Text] [Related]  

  • 12. The case against routine aspirin use for primary prevention in low-risk adults.
    Bailey AL; Smyth SS; Campbell CL
    Am Fam Physician; 2011 Jun; 83(12):1387-90. PubMed ID: 21671539
    [No Abstract]   [Full Text] [Related]  

  • 13. New guidelines refine aspirin prescription. Task force offers recommendation for women and guidance on dosage.
    Harv Heart Lett; 2009 Jun; 19(10):4-5. PubMed ID: 19681207
    [No Abstract]   [Full Text] [Related]  

  • 14. [Primary prevention of cardiovascular diseases with acetylsalicylic acid].
    Waltering A; Hemkens L; Florack C
    Dtsch Med Wochenschr; 2005 Dec; 130(49):2847-52. PubMed ID: 16317615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin for primary prevention of cardiovascular disease?
    Drug Ther Bull; 2009 Nov; 47(11):122-5. PubMed ID: 19887685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: a meta-analysis of randomized trials.
    Berger JS; Lala A; Krantz MJ; Baker GS; Hiatt WR
    Am Heart J; 2011 Jul; 162(1):115-24.e2. PubMed ID: 21742097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin in the primary prevention of cardiovascular disease.
    Galloway CF; Stevenson JC
    Maturitas; 2011 Jan; 68(1):3-4. PubMed ID: 21111550
    [No Abstract]   [Full Text] [Related]  

  • 18. Low-dose aspirin for everyone?
    Johns Hopkins Med Lett Health After 50; 2002 Oct; 14(8):4-5. PubMed ID: 12425276
    [No Abstract]   [Full Text] [Related]  

  • 19. [Aspirin as primary prevention for diabetic patients].
    Fumeaux D; Becerra ME; Philippe J; Louis-Simonet M
    Rev Med Suisse; 2010 Feb; 6(234):244-8. PubMed ID: 20334083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are at-risk New Zealand women receiving recommended cardiovascular preventive therapy?
    Bupha-Intr O; Rose SB; Lawton BA; Elley CR; Dowell AC
    N Z Med J; 2010 Feb; 123(1309):26-36. PubMed ID: 20186240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.